UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: Espranor-2mg-Lyophilisate-SE-BS-MPD

Generated Narrative: MedicinalProductDefinition Espranor-2mg-Lyophilisate-SE-BS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-XXXXXXXXX-00051207, http://ema.europa.eu/fhir/eurdId/461

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Oral lyophilisate

indication:

Substitutionsbehandling för opioidberoende, inom ramen för en medicinsk, social och psykologisk behandling. Behandling med Espranor frystorkad tablett är avsedd för vuxna och ungdomar i åldern 15 år och äldre som har samtyckt till behandling av sitt beroende.

legalStatusOfSupply: Medicinal product subject to special medical prescription

classification: N07BC01

name

productName: Espranor 2 mg frystorkad tablett

part

part: Espranor

type: Invented name part

part

part: 2 mg

type: Strength part

part

part: Frystorkad tablett

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish